Post-COVID-19 Syndrome Clinical Trials
3 recruiting trials for Post-COVID-19 Syndrome. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Post-COVID-19 Syndrome clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Medical University of Vienna (2), First Affiliated Hospital Xi'an Jiaotong University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Transcranial pulse stimulation Verum (device, 1 trial), followed by Transcranial pulse stimulation Sham, Simultaneous cortico-spinal magnetic resonance imaging, Serum.
Track Post-COVID-19 Syndrome trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Transcranial Pulse Stimulation (TPS) in Post-COVID-19
The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue,...
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to...
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
The Study objective is to measure retinal neurovascular coupling and blood flow parameters in patients previously infected with COVID-19, long COVID-19 and healthy age- and sex-...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Post-COVID-19 Syndrome, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Post-COVID-19 Syndrome, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Post-COVID-19 Syndrome, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.